[<superscript>18</superscript>F]FDG PET/CT in a Case of Mycosis Fungoides Showing an Unusual Adverse Reaction to Mogamulizumab: Correlation Between Imaging and Histological Findings.
In: Cancer Biotherapy & Radiopharmaceuticals, Jg. 38 (2023-05-01), Heft 4, S. 268-272
academicJournal
Zugriff:
A 73-year-old female patient, affected by mycosis fungoides (MF), discontinued mogamulizumab, after initial clinical benefit, due to the onset of generalized erythema. Follow-up positron emission computed tomography (PET/CTs) carried out at 3 weeks and 6 months after therapy discontinuation showed, with respect to baseline PET/CT scan, a progressively increasing number of hypermetabolic enlarged lymph nodes suspected for a neoplastic involvement, but with histology indicative of an inflammatory reaction. After sequential therapy with corticosteroids and methotrexate, a complete remission was registered at 18F-fluorodeoxyglucose ([18F]FDG) PET/CT performed at 12 months after mogamulizumab interruption. The case we describe highlights the usefulness of serial examinations with [18F]FDG PET/CT in an MF patient presenting an unusual adverse reaction to mogamulizumab. [ABSTRACT FROM AUTHOR]
Titel: |
[<superscript>18</superscript>F]FDG PET/CT in a Case of Mycosis Fungoides Showing an Unusual Adverse Reaction to Mogamulizumab: Correlation Between Imaging and Histological Findings.
|
---|---|
Autor/in / Beteiligte Person: | Filippi, Luca ; Proietti, Ilaria ; Petrozza, Vincenzo ; Aversa, Sara ; Fiorentino, Francesco ; Potenza, Concetta ; Bagni, Oreste ; Schillaci, Orazio ; Cantonetti, Maria |
Zeitschrift: | Cancer Biotherapy & Radiopharmaceuticals, Jg. 38 (2023-05-01), Heft 4, S. 268-272 |
Veröffentlichung: | 2023 |
Medientyp: | academicJournal |
ISSN: | 1084-9785 (print) |
DOI: | 10.1089/cbr.2022.0086 |
Schlagwort: |
|
Sonstiges: |
|